Tirzepatide substance synthesis presents a complex challenge due to its complex chemical structure. Scientists are continuously striving to optimize the manufacture process, aiming for high yields and purity while minimizing impacts. Once synthesized, Tirzepatide API requires a robust supply chain infrastructure to ensure timely delivery to patient